Stay updated on XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page
- Check7 days agoChange DetectedThe clinical trial record is now displayed, including its study design, eligibility criteria, treatment arms, outcome measures, participating locations, and publication and record-history details.SummaryDifference81%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page remains a 403 error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice announces transition-related updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study details with an access-denied message. This indicates the study record content is currently inaccessible on the page.SummaryDifference16%

Stay in the know with updates to XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page.